nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—AGTR1—pancreatic cancer	0.293	0.614	CbGaD
Telmisartan—PPARG—pancreatic cancer	0.185	0.386	CbGaD
Telmisartan—SLCO1B3—Docetaxel—pancreatic cancer	0.0374	0.101	CbGbCtD
Telmisartan—ABCC2—Tamoxifen—pancreatic cancer	0.034	0.092	CbGbCtD
Telmisartan—ABCG2—Tamoxifen—pancreatic cancer	0.0308	0.0831	CbGbCtD
Telmisartan—ABCG2—Erlotinib—pancreatic cancer	0.0262	0.0707	CbGbCtD
Telmisartan—ABCC2—Irinotecan—pancreatic cancer	0.0261	0.0706	CbGbCtD
Telmisartan—ABCG2—Irinotecan—pancreatic cancer	0.0236	0.0638	CbGbCtD
Telmisartan—ABCG2—Fluorouracil—pancreatic cancer	0.0227	0.0613	CbGbCtD
Telmisartan—ABCC2—Docetaxel—pancreatic cancer	0.0192	0.0517	CbGbCtD
Telmisartan—ABCC2—Sunitinib—pancreatic cancer	0.0191	0.0515	CbGbCtD
Telmisartan—ABCG2—Docetaxel—pancreatic cancer	0.0173	0.0468	CbGbCtD
Telmisartan—ABCG2—Sunitinib—pancreatic cancer	0.0172	0.0466	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—pancreatic cancer	0.0143	0.0386	CbGbCtD
Telmisartan—CYP2C19—Tamoxifen—pancreatic cancer	0.0138	0.0372	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—pancreatic cancer	0.0129	0.0349	CbGbCtD
Telmisartan—ABCB1—Tamoxifen—pancreatic cancer	0.0111	0.03	CbGbCtD
Telmisartan—ABCB1—Gemcitabine—pancreatic cancer	0.00956	0.0258	CbGbCtD
Telmisartan—ABCB1—Erlotinib—pancreatic cancer	0.00944	0.0255	CbGbCtD
Telmisartan—ABCB1—Irinotecan—pancreatic cancer	0.00852	0.023	CbGbCtD
Telmisartan—ABCB1—Docetaxel—pancreatic cancer	0.00624	0.0169	CbGbCtD
Telmisartan—ABCB1—Sunitinib—pancreatic cancer	0.00622	0.0168	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—pancreatic cancer	0.00465	0.0126	CbGbCtD
Telmisartan—ABCC2—bile duct—pancreatic cancer	0.00416	0.415	CbGeAlD
Telmisartan—ABCC2—bile—pancreatic cancer	0.00319	0.319	CbGeAlD
Telmisartan—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.00208	1	CbGdCrCtD
Telmisartan—Azilsartan medoxomil—AGTR1—pancreatic cancer	0.00188	0.48	CrCbGaD
Telmisartan—Olmesartan—AGTR1—pancreatic cancer	0.000894	0.228	CrCbGaD
Telmisartan—Candesartan—AGTR1—pancreatic cancer	0.000695	0.178	CrCbGaD
Telmisartan—PPARG—islet of Langerhans—pancreatic cancer	0.000661	0.0661	CbGeAlD
Telmisartan—PPARG—pancreas—pancreatic cancer	0.000465	0.0465	CbGeAlD
Telmisartan—Losartan—AGTR1—pancreatic cancer	0.000448	0.114	CrCbGaD
Telmisartan—PPARG—digestive system—pancreatic cancer	0.000397	0.0397	CbGeAlD
Telmisartan—ABCC2—digestive system—pancreatic cancer	0.000349	0.0349	CbGeAlD
Telmisartan—CYP2C19—digestive system—pancreatic cancer	0.0003	0.03	CbGeAlD
Telmisartan—ABCB1—islet of Langerhans—pancreatic cancer	0.000209	0.0209	CbGeAlD
Telmisartan—ABCB1—pancreas—pancreatic cancer	0.000147	0.0147	CbGeAlD
Telmisartan—ABCB1—digestive system—pancreatic cancer	0.000126	0.0125	CbGeAlD
Telmisartan—Infestation—Epirubicin—pancreatic cancer	7.02e-05	0.000669	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—pancreatic cancer	7e-05	0.000668	CcSEcCtD
Telmisartan—Arthralgia—Docetaxel—pancreatic cancer	6.92e-05	0.00066	CcSEcCtD
Telmisartan—Chest pain—Docetaxel—pancreatic cancer	6.92e-05	0.00066	CcSEcCtD
Telmisartan—Myalgia—Docetaxel—pancreatic cancer	6.92e-05	0.00066	CcSEcCtD
Telmisartan—Nausea—Sunitinib—pancreatic cancer	6.92e-05	0.00066	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—pancreatic cancer	6.9e-05	0.000658	CcSEcCtD
Telmisartan—Asthenia—Irinotecan—pancreatic cancer	6.89e-05	0.000657	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—pancreatic cancer	6.88e-05	0.000656	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	6.87e-05	0.000655	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—pancreatic cancer	6.82e-05	0.00065	CcSEcCtD
Telmisartan—Urinary tract infection—Epirubicin—pancreatic cancer	6.82e-05	0.00065	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—pancreatic cancer	6.81e-05	0.000649	CcSEcCtD
Telmisartan—Hypersensitivity—Fluorouracil—pancreatic cancer	6.77e-05	0.000646	CcSEcCtD
Telmisartan—Dry mouth—Docetaxel—pancreatic cancer	6.77e-05	0.000645	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	6.77e-05	0.000645	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—pancreatic cancer	6.73e-05	0.000641	CcSEcCtD
Telmisartan—Asthenia—Gemcitabine—pancreatic cancer	6.71e-05	0.00064	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—pancreatic cancer	6.69e-05	0.000638	CcSEcCtD
Telmisartan—Hepatobiliary disease—Epirubicin—pancreatic cancer	6.64e-05	0.000633	CcSEcCtD
Telmisartan—Oedema—Docetaxel—pancreatic cancer	6.64e-05	0.000633	CcSEcCtD
Telmisartan—Anaphylactic shock—Docetaxel—pancreatic cancer	6.64e-05	0.000633	CcSEcCtD
Telmisartan—Epistaxis—Epirubicin—pancreatic cancer	6.62e-05	0.000631	CcSEcCtD
Telmisartan—Pruritus—Gemcitabine—pancreatic cancer	6.61e-05	0.000631	CcSEcCtD
Telmisartan—Infection—Docetaxel—pancreatic cancer	6.59e-05	0.000628	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—pancreatic cancer	6.58e-05	0.000628	CcSEcCtD
Telmisartan—Diarrhoea—Irinotecan—pancreatic cancer	6.57e-05	0.000626	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—pancreatic cancer	6.53e-05	0.000623	CcSEcCtD
Telmisartan—Shock—Docetaxel—pancreatic cancer	6.53e-05	0.000622	CcSEcCtD
Telmisartan—Nervous system disorder—Docetaxel—pancreatic cancer	6.51e-05	0.00062	CcSEcCtD
Telmisartan—Pruritus—Fluorouracil—pancreatic cancer	6.5e-05	0.00062	CcSEcCtD
Telmisartan—Thrombocytopenia—Docetaxel—pancreatic cancer	6.5e-05	0.000619	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—pancreatic cancer	6.49e-05	0.000619	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—pancreatic cancer	6.49e-05	0.000619	CcSEcCtD
Telmisartan—Tachycardia—Docetaxel—pancreatic cancer	6.48e-05	0.000617	CcSEcCtD
Telmisartan—Skin disorder—Docetaxel—pancreatic cancer	6.44e-05	0.000614	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—pancreatic cancer	6.41e-05	0.000611	CcSEcCtD
Telmisartan—Diarrhoea—Gemcitabine—pancreatic cancer	6.4e-05	0.00061	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—pancreatic cancer	6.38e-05	0.000608	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—pancreatic cancer	6.36e-05	0.000607	CcSEcCtD
Telmisartan—Dizziness—Irinotecan—pancreatic cancer	6.35e-05	0.000605	CcSEcCtD
Telmisartan—Anorexia—Docetaxel—pancreatic cancer	6.32e-05	0.000603	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—pancreatic cancer	6.32e-05	0.000602	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—pancreatic cancer	6.31e-05	0.000602	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—pancreatic cancer	6.31e-05	0.000602	CcSEcCtD
Telmisartan—Diarrhoea—Fluorouracil—pancreatic cancer	6.29e-05	0.0006	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—pancreatic cancer	6.27e-05	0.000598	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—pancreatic cancer	6.25e-05	0.000596	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—pancreatic cancer	6.22e-05	0.000593	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—pancreatic cancer	6.21e-05	0.000592	CcSEcCtD
Telmisartan—Hypotension—Docetaxel—pancreatic cancer	6.2e-05	0.000591	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—pancreatic cancer	6.19e-05	0.00059	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—pancreatic cancer	6.19e-05	0.00059	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—pancreatic cancer	6.17e-05	0.000589	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—pancreatic cancer	6.14e-05	0.000585	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—pancreatic cancer	6.12e-05	0.000584	CcSEcCtD
Telmisartan—Vomiting—Irinotecan—pancreatic cancer	6.1e-05	0.000582	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—pancreatic cancer	6.09e-05	0.000581	CcSEcCtD
Telmisartan—Dizziness—Fluorouracil—pancreatic cancer	6.08e-05	0.00058	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—pancreatic cancer	6.07e-05	0.000579	CcSEcCtD
Telmisartan—Rash—Irinotecan—pancreatic cancer	6.05e-05	0.000577	CcSEcCtD
Telmisartan—Dermatitis—Irinotecan—pancreatic cancer	6.05e-05	0.000576	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	6.05e-05	0.000576	CcSEcCtD
Telmisartan—Headache—Irinotecan—pancreatic cancer	6.01e-05	0.000573	CcSEcCtD
Telmisartan—Insomnia—Docetaxel—pancreatic cancer	6e-05	0.000572	CcSEcCtD
Telmisartan—Paraesthesia—Docetaxel—pancreatic cancer	5.96e-05	0.000568	CcSEcCtD
Telmisartan—Vomiting—Gemcitabine—pancreatic cancer	5.94e-05	0.000567	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—pancreatic cancer	5.93e-05	0.000566	CcSEcCtD
Telmisartan—Dyspnoea—Docetaxel—pancreatic cancer	5.92e-05	0.000564	CcSEcCtD
Telmisartan—Somnolence—Docetaxel—pancreatic cancer	5.9e-05	0.000562	CcSEcCtD
Telmisartan—Rash—Gemcitabine—pancreatic cancer	5.9e-05	0.000562	CcSEcCtD
Telmisartan—Dermatitis—Gemcitabine—pancreatic cancer	5.89e-05	0.000562	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—pancreatic cancer	5.89e-05	0.000561	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—pancreatic cancer	5.87e-05	0.00056	CcSEcCtD
Telmisartan—Headache—Gemcitabine—pancreatic cancer	5.86e-05	0.000558	CcSEcCtD
Telmisartan—Flushing—Epirubicin—pancreatic cancer	5.85e-05	0.000557	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—pancreatic cancer	5.85e-05	0.000557	CcSEcCtD
Telmisartan—Vomiting—Fluorouracil—pancreatic cancer	5.84e-05	0.000557	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—pancreatic cancer	5.84e-05	0.000557	CcSEcCtD
Telmisartan—Dyspepsia—Docetaxel—pancreatic cancer	5.84e-05	0.000557	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—pancreatic cancer	5.8e-05	0.000553	CcSEcCtD
Telmisartan—Rash—Fluorouracil—pancreatic cancer	5.8e-05	0.000553	CcSEcCtD
Telmisartan—Dermatitis—Fluorouracil—pancreatic cancer	5.79e-05	0.000552	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—pancreatic cancer	5.78e-05	0.000552	CcSEcCtD
Telmisartan—Decreased appetite—Docetaxel—pancreatic cancer	5.77e-05	0.00055	CcSEcCtD
Telmisartan—Headache—Fluorouracil—pancreatic cancer	5.76e-05	0.000549	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—pancreatic cancer	5.76e-05	0.000549	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—pancreatic cancer	5.74e-05	0.000547	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	5.73e-05	0.000546	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—pancreatic cancer	5.73e-05	0.000546	CcSEcCtD
Telmisartan—Fatigue—Docetaxel—pancreatic cancer	5.72e-05	0.000545	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—pancreatic cancer	5.72e-05	0.000545	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—pancreatic cancer	5.71e-05	0.000545	CcSEcCtD
Telmisartan—Nausea—Irinotecan—pancreatic cancer	5.7e-05	0.000544	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—pancreatic cancer	5.69e-05	0.000542	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—pancreatic cancer	5.68e-05	0.000541	CcSEcCtD
Telmisartan—Constipation—Docetaxel—pancreatic cancer	5.67e-05	0.000541	CcSEcCtD
Telmisartan—Pain—Docetaxel—pancreatic cancer	5.67e-05	0.000541	CcSEcCtD
Telmisartan—Chills—Epirubicin—pancreatic cancer	5.65e-05	0.000539	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—pancreatic cancer	5.63e-05	0.000537	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—pancreatic cancer	5.62e-05	0.000536	CcSEcCtD
Telmisartan—Nausea—Gemcitabine—pancreatic cancer	5.55e-05	0.000529	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—pancreatic cancer	5.52e-05	0.000526	CcSEcCtD
Telmisartan—Erythema—Epirubicin—pancreatic cancer	5.48e-05	0.000523	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—pancreatic cancer	5.48e-05	0.000523	CcSEcCtD
Telmisartan—Feeling abnormal—Docetaxel—pancreatic cancer	5.47e-05	0.000521	CcSEcCtD
Telmisartan—Nausea—Fluorouracil—pancreatic cancer	5.46e-05	0.000521	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—pancreatic cancer	5.45e-05	0.000519	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—pancreatic cancer	5.43e-05	0.000518	CcSEcCtD
Telmisartan—Gastrointestinal pain—Docetaxel—pancreatic cancer	5.43e-05	0.000517	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—pancreatic cancer	5.41e-05	0.000516	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—pancreatic cancer	5.41e-05	0.000516	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—pancreatic cancer	5.4e-05	0.000515	CcSEcCtD
Telmisartan—Tension—Epirubicin—pancreatic cancer	5.38e-05	0.000513	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—pancreatic cancer	5.37e-05	0.000512	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—pancreatic cancer	5.33e-05	0.000508	CcSEcCtD
Telmisartan—Back pain—Epirubicin—pancreatic cancer	5.3e-05	0.000506	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—pancreatic cancer	5.29e-05	0.000504	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—pancreatic cancer	5.27e-05	0.000503	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—pancreatic cancer	5.26e-05	0.000502	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—pancreatic cancer	5.25e-05	0.000501	CcSEcCtD
Telmisartan—Abdominal pain—Docetaxel—pancreatic cancer	5.25e-05	0.0005	CcSEcCtD
Telmisartan—Body temperature increased—Docetaxel—pancreatic cancer	5.25e-05	0.0005	CcSEcCtD
Telmisartan—Chills—Doxorubicin—pancreatic cancer	5.23e-05	0.000499	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—pancreatic cancer	5.21e-05	0.000496	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—pancreatic cancer	5.11e-05	0.000487	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—pancreatic cancer	5.09e-05	0.000485	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—pancreatic cancer	5.07e-05	0.000484	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—pancreatic cancer	5.07e-05	0.000484	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—pancreatic cancer	5.07e-05	0.000483	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—pancreatic cancer	5e-05	0.000477	CcSEcCtD
Telmisartan—Tension—Doxorubicin—pancreatic cancer	4.98e-05	0.000475	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—pancreatic cancer	4.97e-05	0.000474	CcSEcCtD
Telmisartan—Malaise—Epirubicin—pancreatic cancer	4.94e-05	0.000471	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—pancreatic cancer	4.93e-05	0.00047	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—pancreatic cancer	4.93e-05	0.00047	CcSEcCtD
Telmisartan—Syncope—Epirubicin—pancreatic cancer	4.92e-05	0.000469	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—pancreatic cancer	4.91e-05	0.000468	CcSEcCtD
Telmisartan—Hypersensitivity—Docetaxel—pancreatic cancer	4.89e-05	0.000466	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—pancreatic cancer	4.88e-05	0.000465	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—pancreatic cancer	4.85e-05	0.000462	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—pancreatic cancer	4.82e-05	0.00046	CcSEcCtD
Telmisartan—Cough—Epirubicin—pancreatic cancer	4.79e-05	0.000456	CcSEcCtD
Telmisartan—Asthenia—Docetaxel—pancreatic cancer	4.76e-05	0.000454	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—pancreatic cancer	4.73e-05	0.000451	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.71e-05	0.000449	CcSEcCtD
Telmisartan—Pruritus—Docetaxel—pancreatic cancer	4.69e-05	0.000448	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—pancreatic cancer	4.69e-05	0.000447	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—pancreatic cancer	4.67e-05	0.000445	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—pancreatic cancer	4.67e-05	0.000445	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—pancreatic cancer	4.67e-05	0.000445	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—pancreatic cancer	4.65e-05	0.000444	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	4.64e-05	0.000442	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—pancreatic cancer	4.61e-05	0.00044	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—pancreatic cancer	4.58e-05	0.000436	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—pancreatic cancer	4.57e-05	0.000435	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—pancreatic cancer	4.56e-05	0.000435	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—pancreatic cancer	4.55e-05	0.000434	CcSEcCtD
Telmisartan—Diarrhoea—Docetaxel—pancreatic cancer	4.54e-05	0.000433	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—pancreatic cancer	4.48e-05	0.000427	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—pancreatic cancer	4.48e-05	0.000427	CcSEcCtD
Telmisartan—Oedema—Epirubicin—pancreatic cancer	4.48e-05	0.000427	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—pancreatic cancer	4.46e-05	0.000425	CcSEcCtD
Telmisartan—Infection—Epirubicin—pancreatic cancer	4.45e-05	0.000424	CcSEcCtD
Telmisartan—Cough—Doxorubicin—pancreatic cancer	4.43e-05	0.000422	CcSEcCtD
Telmisartan—Shock—Epirubicin—pancreatic cancer	4.4e-05	0.00042	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—pancreatic cancer	4.39e-05	0.000418	CcSEcCtD
Telmisartan—Dizziness—Docetaxel—pancreatic cancer	4.39e-05	0.000418	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—pancreatic cancer	4.38e-05	0.000418	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—pancreatic cancer	4.38e-05	0.000418	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—pancreatic cancer	4.37e-05	0.000416	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—pancreatic cancer	4.35e-05	0.000414	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—pancreatic cancer	4.33e-05	0.000412	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—pancreatic cancer	4.32e-05	0.000412	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—pancreatic cancer	4.32e-05	0.000412	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—pancreatic cancer	4.32e-05	0.000412	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—pancreatic cancer	4.3e-05	0.00041	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	4.29e-05	0.000409	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—pancreatic cancer	4.27e-05	0.000407	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—pancreatic cancer	4.27e-05	0.000407	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—pancreatic cancer	4.22e-05	0.000403	CcSEcCtD
Telmisartan—Vomiting—Docetaxel—pancreatic cancer	4.22e-05	0.000402	CcSEcCtD
Telmisartan—Rash—Docetaxel—pancreatic cancer	4.18e-05	0.000399	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—pancreatic cancer	4.18e-05	0.000399	CcSEcCtD
Telmisartan—Dermatitis—Docetaxel—pancreatic cancer	4.18e-05	0.000398	CcSEcCtD
Telmisartan—Headache—Docetaxel—pancreatic cancer	4.16e-05	0.000396	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.14e-05	0.000395	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—pancreatic cancer	4.14e-05	0.000395	CcSEcCtD
Telmisartan—Infection—Doxorubicin—pancreatic cancer	4.11e-05	0.000392	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.08e-05	0.000389	CcSEcCtD
Telmisartan—Shock—Doxorubicin—pancreatic cancer	4.07e-05	0.000388	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—pancreatic cancer	4.06e-05	0.000387	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.05e-05	0.000387	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—pancreatic cancer	4.05e-05	0.000386	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—pancreatic cancer	4.04e-05	0.000385	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—pancreatic cancer	4.02e-05	0.000383	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—pancreatic cancer	4.02e-05	0.000383	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—pancreatic cancer	4e-05	0.000382	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—pancreatic cancer	3.99e-05	0.00038	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—pancreatic cancer	3.98e-05	0.000379	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—pancreatic cancer	3.95e-05	0.000376	CcSEcCtD
Telmisartan—Nausea—Docetaxel—pancreatic cancer	3.94e-05	0.000376	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—pancreatic cancer	3.94e-05	0.000376	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—pancreatic cancer	3.89e-05	0.000371	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—pancreatic cancer	3.87e-05	0.000369	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.86e-05	0.000368	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—pancreatic cancer	3.86e-05	0.000368	CcSEcCtD
Telmisartan—Constipation—Epirubicin—pancreatic cancer	3.83e-05	0.000365	CcSEcCtD
Telmisartan—Pain—Epirubicin—pancreatic cancer	3.83e-05	0.000365	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.77e-05	0.00036	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—pancreatic cancer	3.75e-05	0.000357	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—pancreatic cancer	3.72e-05	0.000355	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—pancreatic cancer	3.69e-05	0.000352	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—pancreatic cancer	3.69e-05	0.000352	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—pancreatic cancer	3.68e-05	0.000351	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.66e-05	0.000349	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—pancreatic cancer	3.65e-05	0.000348	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—pancreatic cancer	3.6e-05	0.000343	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.57e-05	0.000341	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—pancreatic cancer	3.57e-05	0.00034	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—pancreatic cancer	3.56e-05	0.000339	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—pancreatic cancer	3.54e-05	0.000338	CcSEcCtD
Telmisartan—Pain—Doxorubicin—pancreatic cancer	3.54e-05	0.000338	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—pancreatic cancer	3.54e-05	0.000337	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—pancreatic cancer	3.54e-05	0.000337	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—pancreatic cancer	3.41e-05	0.000325	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.39e-05	0.000323	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—pancreatic cancer	3.3e-05	0.000314	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—pancreatic cancer	3.29e-05	0.000314	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—pancreatic cancer	3.27e-05	0.000312	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—pancreatic cancer	3.27e-05	0.000312	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—pancreatic cancer	3.21e-05	0.000306	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—pancreatic cancer	3.17e-05	0.000302	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—pancreatic cancer	3.06e-05	0.000292	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—pancreatic cancer	3.05e-05	0.000291	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—HES1—pancreatic cancer	3.03e-05	0.000986	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GLI1—pancreatic cancer	3.02e-05	0.000981	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—DTX4—pancreatic cancer	3.02e-05	0.000981	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.99e-05	0.000972	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	2.98e-05	0.000967	CbGpPWpGaD
Telmisartan—Asthenia—Doxorubicin—pancreatic cancer	2.97e-05	0.000283	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—pancreatic cancer	2.96e-05	0.000282	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CNR1—pancreatic cancer	2.95e-05	0.00096	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PPP2R5B—pancreatic cancer	2.93e-05	0.000954	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRP1—pancreatic cancer	2.93e-05	0.000954	CbGpPWpGaD
Telmisartan—Pruritus—Doxorubicin—pancreatic cancer	2.93e-05	0.000279	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—GCG—pancreatic cancer	2.85e-05	0.000928	CbGpPWpGaD
Telmisartan—Vomiting—Epirubicin—pancreatic cancer	2.85e-05	0.000271	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—pancreatic cancer	2.83e-05	0.00027	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—HEY2—pancreatic cancer	2.83e-05	0.000918	CbGpPWpGaD
Telmisartan—Rash—Epirubicin—pancreatic cancer	2.82e-05	0.000269	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—pancreatic cancer	2.82e-05	0.000269	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	2.82e-05	0.000916	CbGpPWpGaD
Telmisartan—Headache—Epirubicin—pancreatic cancer	2.8e-05	0.000267	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—GAST—pancreatic cancer	2.76e-05	0.000897	CbGpPWpGaD
Telmisartan—Dizziness—Doxorubicin—pancreatic cancer	2.74e-05	0.000261	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	2.73e-05	0.000889	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	2.73e-05	0.000889	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	2.71e-05	0.000879	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	2.7e-05	0.000877	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TYMP—pancreatic cancer	2.69e-05	0.000873	CbGpPWpGaD
Telmisartan—Nausea—Epirubicin—pancreatic cancer	2.66e-05	0.000253	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	2.64e-05	0.000859	CbGpPWpGaD
Telmisartan—Vomiting—Doxorubicin—pancreatic cancer	2.63e-05	0.000251	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	2.62e-05	0.000852	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MEN1—pancreatic cancer	2.62e-05	0.000851	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SCT—pancreatic cancer	2.62e-05	0.00085	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HEY1—pancreatic cancer	2.62e-05	0.00085	CbGpPWpGaD
Telmisartan—Rash—Doxorubicin—pancreatic cancer	2.61e-05	0.000249	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—pancreatic cancer	2.61e-05	0.000249	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.6e-05	0.000845	CbGpPWpGaD
Telmisartan—Headache—Doxorubicin—pancreatic cancer	2.59e-05	0.000247	CcSEcCtD
Telmisartan—ABCG2—Metabolism—PRSS1—pancreatic cancer	2.58e-05	0.00084	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	2.57e-05	0.000836	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GLP1R—pancreatic cancer	2.54e-05	0.000825	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	2.53e-05	0.000822	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—DPYD—pancreatic cancer	2.5e-05	0.000812	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCK—pancreatic cancer	2.5e-05	0.000811	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH4—pancreatic cancer	2.48e-05	0.000807	CbGpPWpGaD
Telmisartan—Nausea—Doxorubicin—pancreatic cancer	2.46e-05	0.000235	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	2.43e-05	0.000791	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CNR2—pancreatic cancer	2.43e-05	0.000791	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GLP1R—pancreatic cancer	2.43e-05	0.000791	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KDR—pancreatic cancer	2.43e-05	0.00079	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCL8—pancreatic cancer	2.43e-05	0.00079	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCKAR—pancreatic cancer	2.39e-05	0.000778	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MET—pancreatic cancer	2.38e-05	0.000774	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC2A2—pancreatic cancer	2.37e-05	0.00077	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HSPA1B—pancreatic cancer	2.37e-05	0.00077	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.34e-05	0.000762	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAG2—pancreatic cancer	2.32e-05	0.000754	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NOTCH1—pancreatic cancer	2.29e-05	0.000745	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	2.29e-05	0.000744	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MEN1—pancreatic cancer	2.29e-05	0.000743	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.26e-05	0.000736	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ARG2—pancreatic cancer	2.24e-05	0.000728	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.22e-05	0.000721	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SHH—pancreatic cancer	2.18e-05	0.000709	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH4—pancreatic cancer	2.17e-05	0.000705	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GLP1R—pancreatic cancer	2.17e-05	0.000704	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—EZH2—pancreatic cancer	2.16e-05	0.000701	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IAPP—pancreatic cancer	2.15e-05	0.0007	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—DPYD—pancreatic cancer	2.13e-05	0.000692	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH3—pancreatic cancer	2.11e-05	0.000686	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.1e-05	0.000683	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—pancreatic cancer	2.08e-05	0.000676	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTHLH—pancreatic cancer	2.07e-05	0.000672	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTCH1—pancreatic cancer	2.07e-05	0.000672	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.06e-05	0.00067	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC2A2—pancreatic cancer	2.02e-05	0.000657	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2e-05	0.00065	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HSPA1A—pancreatic cancer	2e-05	0.00065	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP2—pancreatic cancer	1.98e-05	0.000645	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.96e-05	0.000638	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMP—pancreatic cancer	1.96e-05	0.000637	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.95e-05	0.000634	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SST—pancreatic cancer	1.89e-05	0.000615	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.87e-05	0.000607	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.87e-05	0.000606	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAG1—pancreatic cancer	1.85e-05	0.000602	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH3—pancreatic cancer	1.84e-05	0.000599	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CD44—pancreatic cancer	1.83e-05	0.000596	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.8e-05	0.000584	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.78e-05	0.000579	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GCG—pancreatic cancer	1.76e-05	0.000572	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.76e-05	0.000572	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CNR1—pancreatic cancer	1.75e-05	0.000567	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.7e-05	0.000553	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.69e-05	0.000551	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.69e-05	0.000548	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GCG—pancreatic cancer	1.69e-05	0.000548	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—STK11—pancreatic cancer	1.65e-05	0.000538	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.64e-05	0.000533	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SMAD4—pancreatic cancer	1.59e-05	0.000517	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STK11—pancreatic cancer	1.58e-05	0.000515	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GLP1R—pancreatic cancer	1.58e-05	0.000513	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CD44—pancreatic cancer	1.57e-05	0.000509	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—DPYD—pancreatic cancer	1.55e-05	0.000505	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.55e-05	0.000505	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.53e-05	0.000498	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—pancreatic cancer	1.52e-05	0.000495	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.52e-05	0.000494	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GCG—pancreatic cancer	1.5e-05	0.000488	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—pancreatic cancer	1.49e-05	0.000485	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.49e-05	0.000484	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A2—pancreatic cancer	1.47e-05	0.000479	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.43e-05	0.000466	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PRSS1—pancreatic cancer	1.43e-05	0.000465	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.43e-05	0.000465	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TYMS—pancreatic cancer	1.42e-05	0.000462	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—STK11—pancreatic cancer	1.41e-05	0.000459	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.4e-05	0.000454	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SMAD4—pancreatic cancer	1.39e-05	0.000451	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—SRC—pancreatic cancer	1.38e-05	0.000447	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.37e-05	0.000446	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HES1—pancreatic cancer	1.36e-05	0.000441	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—pancreatic cancer	1.34e-05	0.000435	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.33e-05	0.000433	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—pancreatic cancer	1.33e-05	0.000431	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.32e-05	0.000431	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—pancreatic cancer	1.32e-05	0.00043	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—pancreatic cancer	1.31e-05	0.000426	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.3e-05	0.000422	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.3e-05	0.000421	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.28e-05	0.000417	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.25e-05	0.000406	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—pancreatic cancer	1.25e-05	0.000405	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.24e-05	0.000403	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—pancreatic cancer	1.23e-05	0.0004	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TYMS—pancreatic cancer	1.21e-05	0.000395	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ARG2—pancreatic cancer	1.21e-05	0.000394	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—pancreatic cancer	1.21e-05	0.000392	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—pancreatic cancer	1.19e-05	0.000386	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH1—pancreatic cancer	1.17e-05	0.000381	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.16e-05	0.000377	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOE—pancreatic cancer	1.16e-05	0.000376	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—pancreatic cancer	1.15e-05	0.000373	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CD44—pancreatic cancer	1.14e-05	0.000371	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—pancreatic cancer	1.14e-05	0.00037	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—pancreatic cancer	1.14e-05	0.000369	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TSC2—pancreatic cancer	1.13e-05	0.000368	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.13e-05	0.000367	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOE—pancreatic cancer	1.11e-05	0.00036	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.1e-05	0.000356	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GCG—pancreatic cancer	1.09e-05	0.000356	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—pancreatic cancer	1.09e-05	0.000353	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.08e-05	0.000353	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMP—pancreatic cancer	1.06e-05	0.000344	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—pancreatic cancer	1.04e-05	0.000339	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.04e-05	0.000338	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.04e-05	0.000337	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKBIA—pancreatic cancer	1.03e-05	0.000336	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—STK11—pancreatic cancer	1.03e-05	0.000334	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH1—pancreatic cancer	1.02e-05	0.000333	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.02e-05	0.00033	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—pancreatic cancer	1.01e-05	0.000328	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—pancreatic cancer	1e-05	0.000325	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—pancreatic cancer	1e-05	0.000325	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGF—pancreatic cancer	9.89e-06	0.000322	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOE—pancreatic cancer	9.87e-06	0.000321	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—pancreatic cancer	9.68e-06	0.000315	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.68e-06	0.000315	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.6e-06	0.000312	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.34e-06	0.000304	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	9.18e-06	0.000298	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—pancreatic cancer	9.12e-06	0.000296	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.95e-06	0.000291	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—pancreatic cancer	8.91e-06	0.00029	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMS—pancreatic cancer	8.85e-06	0.000288	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.82e-06	0.000287	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—pancreatic cancer	8.8e-06	0.000286	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GLP1R—pancreatic cancer	8.75e-06	0.000284	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.71e-06	0.000283	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—pancreatic cancer	8.61e-06	0.00028	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—DPYD—pancreatic cancer	8.6e-06	0.00028	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—pancreatic cancer	8.55e-06	0.000278	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GLP1R—pancreatic cancer	8.54e-06	0.000277	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.53e-06	0.000277	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—DPYD—pancreatic cancer	8.4e-06	0.000273	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	8.16e-06	0.000265	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.08e-06	0.000263	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	8e-06	0.00026	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A2—pancreatic cancer	7.97e-06	0.000259	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	7.93e-06	0.000258	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.91e-06	0.000257	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—pancreatic cancer	7.83e-06	0.000255	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.8e-06	0.000253	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—pancreatic cancer	7.67e-06	0.000249	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—pancreatic cancer	7.37e-06	0.00024	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—pancreatic cancer	7.32e-06	0.000238	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.21e-06	0.000234	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOE—pancreatic cancer	7.2e-06	0.000234	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—pancreatic cancer	7.12e-06	0.000231	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.1e-06	0.000231	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—pancreatic cancer	7.05e-06	0.000229	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—pancreatic cancer	6.91e-06	0.000225	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—pancreatic cancer	6.86e-06	0.000223	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—pancreatic cancer	6.83e-06	0.000222	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—pancreatic cancer	6.8e-06	0.000221	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—pancreatic cancer	6.76e-06	0.00022	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—pancreatic cancer	6.66e-06	0.000217	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—pancreatic cancer	6.63e-06	0.000215	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—pancreatic cancer	6.5e-06	0.000211	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—pancreatic cancer	6.46e-06	0.00021	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CD44—pancreatic cancer	6.32e-06	0.000206	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—pancreatic cancer	6.3e-06	0.000205	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—pancreatic cancer	6.27e-06	0.000204	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.19e-06	0.000201	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CD44—pancreatic cancer	6.17e-06	0.000201	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—pancreatic cancer	6.14e-06	0.0002	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.13e-06	0.000199	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GCG—pancreatic cancer	6.06e-06	0.000197	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—pancreatic cancer	5.98e-06	0.000195	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—pancreatic cancer	5.93e-06	0.000193	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GCG—pancreatic cancer	5.92e-06	0.000192	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—pancreatic cancer	5.91e-06	0.000192	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—pancreatic cancer	5.9e-06	0.000192	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—pancreatic cancer	5.71e-06	0.000186	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—STK11—pancreatic cancer	5.7e-06	0.000185	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—STK11—pancreatic cancer	5.56e-06	0.000181	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—pancreatic cancer	5.51e-06	0.000179	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—pancreatic cancer	5.49e-06	0.000179	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—pancreatic cancer	5.39e-06	0.000175	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.35e-06	0.000174	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—pancreatic cancer	5.09e-06	0.000165	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—pancreatic cancer	4.98e-06	0.000162	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—pancreatic cancer	4.93e-06	0.00016	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.9e-06	0.000159	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	4.88e-06	0.000159	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMS—pancreatic cancer	4.78e-06	0.000156	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—pancreatic cancer	4.67e-06	0.000152	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—pancreatic cancer	4.52e-06	0.000147	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—pancreatic cancer	4.37e-06	0.000142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—pancreatic cancer	4.32e-06	0.000141	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—pancreatic cancer	4.3e-06	0.00014	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—pancreatic cancer	4.16e-06	0.000135	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOE—pancreatic cancer	3.99e-06	0.00013	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—pancreatic cancer	3.98e-06	0.00013	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOE—pancreatic cancer	3.89e-06	0.000127	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—pancreatic cancer	3.82e-06	0.000124	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.77e-06	0.000123	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.6e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.51e-06	0.000114	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.47e-06	0.000113	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—pancreatic cancer	3.4e-06	0.000111	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—pancreatic cancer	3.39e-06	0.00011	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.16e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.09e-06	0.0001	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—pancreatic cancer	3.03e-06	9.86e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.76e-06	8.96e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.73e-06	8.88e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.69e-06	8.75e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.67e-06	8.67e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—pancreatic cancer	2.48e-06	8.06e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.38e-06	7.74e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—pancreatic cancer	2.33e-06	7.56e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.68e-06	5.46e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.64e-06	5.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.37e-06	4.46e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—pancreatic cancer	1.34e-06	4.36e-05	CbGpPWpGaD
